Last reviewed · How we verify

NCT06340191: PIlatesuja

Cueing and Pilates in Low Back Pain

Completed NA Last updated 1 April 2024
What this trial tests

NA trial testing Pilates with cueing in Low Back Pain in 67 participants. Completed in 26 February 2024.

Timeline
2 May 2023
Primary endpoint
20 February 2024
26 February 2024

Quick facts

Lead sponsorUniversity of Jaén
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment67
Start date2 May 2023
Primary completion20 February 2024
Estimated completion26 February 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Jaén

Who can join

Adults 18 to 65, any sex, with Low Back Pain or Pilates Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intervention involved two groups participating in supervised Pilates sessions, twice a week for 8 weeks, featuring a mix of mat and props-based exercises. Group 1 received additional cueing training to enhance alignment, muscle engagement, and movement technique, while Group 2 underwent the same Pilates regimen without this cueing component.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Importance of Mind-Body in Pilates Method in Patients with Chronic Non-Specific Low Back Pain-A Randomized Controlled Trial.
    Vera-Saura P, Agudo-Pavón J, Velázquez-Torres DM, Martín-Alemán M, et al · · 2024 · cited 3× · PMID 39200873 · DOI 10.3390/jcm13164731

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other University of Jaén trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06340191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing